Clinical consequences of CD4+ T cell ageing include increased vulnerability to infections, decreased responsiveness to vaccines, autoimmune diseases, and a higher risk of age-related and inflammation-associated conditions like cardiovascular disease, neurodegenerative disorders, and cancer.82 Addressing CD4+ T cell ageing is challenging, but potential therapies are emerging. This evidence concerns the gene CD4 and cancer.